ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer.

Ming Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.